Week 5 - Cardiac continued Flashcards

1
Q

Mechanism of Cardiac Glycosides `

A

Inhibit sodium/potassium pump to increase intracellular Calcium during depolarization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What effect do cardiac glycosides have on the conduction of SA to AV?

A

Slows conduction - Always check HR before giving!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
Cardiac Glycoside have: 
\_\_\_\_\_\_\_ inotropic effect 
\_\_\_\_\_\_\_ chronotropic effect 
\_\_\_\_\_\_\_ dromotopic effect 
\_\_\_\_\_\_\_ stroke volume 
\_\_\_\_\_\_\_ cardiac output 
\_\_\_\_\_\_\_ peripheral and lung fluid retention 
\_\_\_\_\_\_\_ fluid excretion
A
  • Positive inotropic effect
  • Negative chronotropic effect
  • Negative dromotopic effect
  • Increases stroke volume
  • Increases cardiac output
  • Decreases peripheral and lung fluid retention
  • Increases fluid excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Indications for cardiac glycosides

A

CHF, A Fib/flutter, paroxysmal atrial tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cardiac glycoside prototype

A

Digoxin (Lanoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Digoxin dosage (PO, IV, Elderly, children )

A

PO: 0.5 - 1mg initially in 2 divided doses (digitalization) , then 0.125 - 0.5 mg/day for maintenance

IV: same as PO but given over 5 min

Elderly: 0.125 mg/day
Children: Doses are ordered in mcg in elixir form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Digoxin absorption (Oral, Liquid)

A

Oral: 60-70%
Liquid: 90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Digoxin distribution (protein bound and its implication)

A

LOW protein bound - means there is a lot of active form circulation and thus higher risk for toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Digoxin half life

A

30-40 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Digoxin excretion

A

70% urine through kidney - thus higher risk for toxicity in renal patients
30% by liver metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Quinidine, Verapamil, Flecainide ______ serum digoxin levels

A

Increase serum digoxin levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Antacids _____ digoxin levels by

A

Antacids decrease digoxin levels by decreasing absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Thiazides and loop diuretics ______ risk for toxicity because

A

Increase risk for toxicity because they can cause hypokalemia, which intensifies effects of digitalis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hypomagnesemia, hypercalcemia _____ risk for toxicity

A

Increase risk for toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hypokalemia _____ effects of digitalis

A

Hypokalemia intensifies effects of digitalis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Digoxin and Ginseng

A

Ginseng - falsely elevates digoxin levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Digoxin and St. John’s Wort

A

St. John’s Wort - decreases absorption and thus serum level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Digoxin and Hawthorn

A

Hawthorn - increases effect of digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Digoxin and Aloe

A

Aloe - increases potassium loss, causing hypokalemia which can lead to digitalis toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Digoxin and Ma Huang

A

Ma Huang - increases risk for toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Digoxin and Licorice

A

Licorice - potentiates effects of digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Therapeutic serum level of Digoxin

A

0.5 - 2.0 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

The therapeutic serum level is _______. This plus the low PB indicates ______ risk for ______.

A

The therapeutic serum level is narrow. This plus the low PB indicates high risk for toxicity.

24
Q

Signs and symptoms of digitalis toxicity (8)

A

*Bradycardia, PVC, cardiac dysrhythmias,visual disturbances (green and yellow halos), blurred vision, confusion/delirium H/A, N/V

25
Q

Who are at greater risk for digitalis toxicity?

A

Elderly and renal patients

26
Q

When giving digoxin, always check (4)

A
  • Serum potassium
  • Baseline apical pulse rate (do not give if below 60)
  • BUN and creatinine
  • Signs and symptoms of toxicity
27
Q

Carvedilol (Coreg) classification

A

3rd generation Beta blocker (beta receptor antagonist) - NON-selective

28
Q

Carvedilol mechanism

A

-Blocks beta 1, beta 2, alpha 1
It’s an ANTIOXIDANT
-Protects against free radicals causing damage to nucleic acids, proteins, and lipids (which are linked to CAD, atherosclerosis)
-Protects from further inflammatory damage or change

29
Q

Carvedilol is NOT for… (4)

A

COPD, CHF, Asthma, DM

30
Q

When should Carvedilol be given?

A

Early stages of HF to slow progression to CHF

31
Q

What is the primary line of therapy for majority of patients with HF?

A

Diuretics

32
Q

Three categories of diuretics

A

Thiazides, Loop, Potassium sparing

33
Q

Diuretic mechanism

A

Produce net loss of sodium and water acting directly on the kidney to decrease acute symptoms of HF that result from fluid retention (such as dyspnea, edema)

34
Q

Thiazide mechanism

A

Inhibits active transport of Cl-Na in the cortical diluting segment of the ascending limb of the Loop of Henle

35
Q

Thiazide example

A

Hydrochlorothiazide (HCTZ)

36
Q

Loop mechanism

A

Inhibits active transport of Cl-Na-K in the thick portion of the ascending limb of the Loop of Henle

37
Q

Loop example

A

Furosemide (Lasix)

38
Q

Potassium sparing mechanism

A
  • Inhibits REABSORPTION of Na in the distal convoluted and collecting tubules
  • BLOCKS aldosterone production
39
Q

What kind of effect do potassium sparing diuretics have on the heart?

A

Cardioprotective effect - blocks aldosterone in the heart and blood vessels to promote cardiac remodeling (repair inflammation)

40
Q

What can use of potassium sparing diuretics lead to?

A

Hyperkalemia

41
Q

Potassium sparing example

A

Spironolactone (Aldactone)

42
Q

What is carbonic anhydrase?

A

Enzymes found in the proximal convoluted tubule in the kidney that helps maintain balance of hydrogen ion and bicarbonate in our bodies

43
Q

Carbonic Anhydrase Inhibitors - mechanism

A

Inhibits action of carbonic anhydrase - causes Na, K, HCO excretion to make pH of kidney tubules alkaline and alkalinizes the urine

44
Q

Carbonic Anhydrase Inhibitors - uses (2)

A
  • Primarily used to decrease IOP in chronic open angle glaucoma
  • Can also alkalinize urine in rhabdomyolisis (alkalinizing = protects integrity of tubules)
45
Q

Carbonic Anhydrase Inhibitor protoype

A

Acetazolamide (Diamox)

46
Q

Acetazolamide (Diamox) classification

A

Carbonic Anhydrase Inhibitor

47
Q

Acetazolamide (Diamox) side effects (5)

A

Fluid and electrolyte imbalances, metabolic acidosis, N/V, confusion, orthostatic hypotension

48
Q

Acetazolamide (Diamox) adverse reactions (3)

A

Hemolytic anemia, renal calculi, crystalluria

49
Q

Osmotic Diuretic mechanism

A

Pulls large amounts of fluid into the urine by osmotic effect

50
Q

Osmotic Diuretic uses (2)

A
  • Decrease IOP or intracranial pressure

- Prevent kidney failure in Cisplatin chemotherapy

51
Q

Osmotic Diuretic prototype

A

Mannitol (Osmitrol)

52
Q

Mannitol mechanism

A

As a sugar, pulls large amounts of fluid into the urin by osmotic pull of the sugar

53
Q

Mannitol side effects (3)

A

N/V, fluid and electrolyte imbalance, pulmonary edema

54
Q

Mannitol contraindications (2)

A
  • HF - because if you’re increasing intravascular volume, you further congest the HF patient
  • Renal Failure - they’re not making urine so they cannot get rid of the fluid you’re pulling out
55
Q

Mannitol can ______ in vial if exposed to ________. Do not infuse if ______ are present.

A

Mannitol can crystallize in vial if exposed to low temperature. Do not infuse if crystals are present.